Benefits
Documented curcumin bioavailability enhancement
The famous 2,000% curcumin bioavailability enhancement was documented using BioPerine® specifically. The trial established that 20 mg BioPerine® combined with 2,000 mg curcumin produced dramatically higher plasma curcumin levels than curcumin alone — foundational evidence for the standard curcumin+piperine combination.
Multi-compound bioavailability research
BioPerine® has documented bioavailability enhancement for resveratrol, CoQ10, beta-carotene, selenium, vitamin B6, water-soluble vitamins, fat-soluble vitamins, and various amino acids. The breadth of validated co-administration research is unmatched in the absorption-enhancer category.
Quality control and standardization
Sabinsa's 95% piperine standardization provides reproducible piperine content batch-to-batch. The standardization is what enables consistent bioavailability-enhancement effects across clinical trials and consumer products.
Clinical trial validation in many products
BioPerine® appears in clinical formulations across categories — joint supplements, nootropics, metabolic support, antioxidants — providing trial-validated bioavailability data. Consumers seeing BioPerine® on labels can confirm the absorption enhancer has been validated in research.
Thermogenic contribution
Beyond pure bioavailability enhancement, BioPerine® contributes modest thermogenic effects in metabolic supplement formulations. Effects are small but mechanistically complementary to other thermogenic ingredients.
FDA GRAS status
BioPerine® has FDA Generally Recognized as Safe (GRAS) status — established quality control and safety documentation. Important for clinical-grade supplement formulations targeting medical or quasi-medical applications.
Mechanism of action
Hepatic and intestinal enzyme inhibition
BioPerine® piperine inhibits hepatic and intestinal CYP3A4, UGT, and other drug-metabolizing enzymes. Inhibition extends the systemic availability of co-administered nutrients and medications — the foundational bioavailability-enhancement mechanism.
Intestinal absorption enhancement
Piperine modulates intestinal epithelial cell membrane fluidity and brush border enzymes, supporting enhanced absorption of poorly-permeable compounds. Mechanism contributes to the broad-spectrum absorption enhancement across structurally diverse co-administered compounds.
P-glycoprotein efflux pump inhibition
Piperine inhibits P-glycoprotein, an efflux pump that normally removes compounds from cells back into the gut lumen. Inhibition increases intracellular retention of co-administered compounds — important mechanism for poorly-absorbed nutrients.
Clinical trials
A randomized crossover trial documented 2,000% (20-fold) increase in curcumin bioavailability when 20 mg BioPerine® was co-administered with 2,000 mg curcumin.
Clinical population described in trial publication.
A randomized crossover trial documented 2,000% (20-fold) increase in curcumin bioavailability when 20 mg BioPerine® was co-administered with 2,000 mg curcumin. Foundational evidence for the curcumin+piperine combination protocol used in essentially every quality curcumin supplement.
Multiple clinical trials document BioPerine® bioavailability enhancement for resveratrol, CoQ10, beta-carotene, water-soluble vitamins, fat-soluble vitamins, selenium, and amino acids.
Clinical population described in trial publication.
Multiple clinical trials document BioPerine® bioavailability enhancement for resveratrol, CoQ10, beta-carotene, water-soluble vitamins, fat-soluble vitamins, selenium, and amino acids. Breadth of validated co-administration research supports broad supplement formulation use.
BioPerine® safety has been documented across long-term clinical trial use at typical 5-20 mg doses.
Clinical population described in trial publication.
BioPerine® safety has been documented across long-term clinical trial use at typical 5-20 mg doses. FDA GRAS status reflects this safety documentation. Drug interaction warnings apply due to CYP3A4 inhibition.